Prof.Dr.GŁnter Valet,Classimed web site

CLASSIF1 Classification

Pretherapeutic Identification of High Risk AML Patients

fig.1: Database      > fig.2

fig.1 database

- Eight patient and clinical chemistry parameters, one overall survival (OS) indicator for clinical outcome, 25 cytogenetic abnormalities and 36 flow cytometric immunophenotype parameters at diagnosis were available for classification. One color indirect (FITC-F(ab')2 fragments (*external link L2) immunophenotypes were used throughout the study for reasons of compatibility with the early determinations of the multicenter trial.

© 2024 G.Valet
last Update: Jun 03,2022
first display: Mar 31,2003